Published in Medical Letter on the CDC and FDA, May 25th, 2008
The open-label, non-randomized registry will be conducted in at least 10 clinical sites in the United States and include at least 1,600 patients. The study will gather data on patient characteristics...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.